These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15239350)

  • 1. Evolution of dilated cardiomyopathy (DCM) from idiopathic hypertrophic cardiomyopathy (IHCM) vs. inflammatory dilated cardiomyopathy (DCMi): a rare case of sudden death in an 8-year-old boy.
    Dettmeyer R; Schmidt P; Kandolf R; Madea B
    Pathol Res Pract; 2004; 200(5):411-5; discussion 417-21. PubMed ID: 15239350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathological study in sudden death of primary cardiomyopathy: a report of 19 cases].
    Li Y; Gu Y
    Fa Yi Xue Za Zhi; 1997; 13(1):23-4, 8 inside back cover. PubMed ID: 9644155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial Cx43 expression in the cases of sudden death due to dilated cardiomyopathy.
    Chen X; Zhang Y
    Forensic Sci Int; 2006 Oct; 162(1-3):170-3. PubMed ID: 16887310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sudden cardiac death in the young.
    Gow RM
    Can J Cardiol; 1996 Nov; 12(11):1157-60. PubMed ID: 9191508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Familial cardiomyopathy with different clinical features in individual members].
    Kudo K; Yamada M; Imai H; Katagiri M; Ozawa S; Ida Y; Okada R
    J Cardiol; 1987 Dec; 17(4):907-14. PubMed ID: 3506615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspects of molecular mechanisms in myocardial hypertrophy, particular morphological changes and cell bioenergetic characteristics in patients with dilated cardiomyopathy.
    Branishte T; Minciuna V; Braniste A
    Rev Med Chir Soc Med Nat Iasi; 2013; 117(4):851-6. PubMed ID: 24502060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathological study of unexpected sudden death clustered in family or village in Yunnan province: report of 29 cases of autopsy].
    Wang HY; Zhao H; Song LF; Huang WL; Niu CL; Li ZX; Yang CF; Liu XB; Liu JH; Yang L; Zhao S; Ren JM; Shi GQ; Zhang J; Pu JL; Yang YJ; Zeng G
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(31):2209-14. PubMed ID: 18001532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac dysrhythmias in children with idiopathic dilated or hypertrophic cardiomyopathy.
    Müller G; Ulmer HE; Hagel KJ; Wolf D
    Pediatr Cardiol; 1995; 16(2):56-60. PubMed ID: 7540289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage.
    Fujiwara H; Onodera T; Tanaka M; Shirane H; Kato H; Yoshikawa J; Osakada G; Sasayama S; Kawai C
    Jpn Circ J; 1984 Nov; 48(11):1210-4. PubMed ID: 6542151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of dilated cardiomyopathy from hypertrophic obstructive cardiomyopathy in a child.
    Lin YT; Wu MH; Wang JK; Lue HC
    J Formos Med Assoc; 1998 Jun; 97(6):416-9. PubMed ID: 9650471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictive value of QT interval dynamicity for sudden death in patients with idiopathic dilated cardiomyopathy].
    Bao MW; Tan TT; Yu SB; Chen K; Huang CX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec; 38(12):1093-7. PubMed ID: 21215145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant familial cardiomyopathy with sudden death, typical asymmetric septal hypertrophy and dilated cardiomyopathy-like features].
    Seo T; Yokota Y; Maehashi N; Takarada A; Kubo M; Toh S; Nakanishi O; Masuda J; Fujitani K; Fukuzaki H
    J Cardiogr; 1986 Mar; 16(1):81-94. PubMed ID: 3782892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertrophic obstructive cardiomyopathy in child. About two cases].
    Thiam M; Ka S; Ndiaye R; Fall PD; Mbaye FK; Imbert P
    Dakar Med; 2004; 49(3):215-7. PubMed ID: 15776621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Unclassified cardiomyopathies: subspecies and their transformation].
    Ikeda Y; Kawai S; Okada R; Yamaguchi H
    J Cardiol; 1998 Feb; 31(2):91-7. PubMed ID: 9513036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis of hypertrophic and dilated cardiomyopathy].
    Ikeda H; Imaizumi T
    Nihon Rinsho; 2000 Jan; 58(1):86-92. PubMed ID: 10885294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural cell adhesion molecule expression in dilated cardiomyopathy is associated with intramyocardial inflammation and hypertrophy.
    Ostermann K; Schultheiss HP; Noutsias M
    Int J Cardiol; 2017 Aug; 241():322-325. PubMed ID: 28343767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myocardial disease mortality in children and young adults. A population-based observational study].
    Morentin B; Suárez-Mier MP; Aguilera B; Bodegas A
    Rev Esp Cardiol; 2006 Mar; 59(3):238-46. PubMed ID: 16712748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological analysis of hypertrophic cardiomyopathy simulating dilated cardiomyopathy.
    Kawashima T; Yokota Y; Yokoyama M; Itoh H
    Acta Pathol Jpn; 1993 Jun; 43(6):304-12. PubMed ID: 8346707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between myocardial histological changes and ventricular tachycardia in cardiomyopathy: a study by 24-hour ECG-monitoring and endomyocardial biopsy.
    Segawa I; Suzuki T; Kato M; Tashiro A; Satodate R
    Heart Vessels Suppl; 1990; 5():37-40. PubMed ID: 2093710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.